PER

0.00%

10.5¢ percheron therapeutics limited

Ann: Appendix 4E and Annual Report, page-27

First 27 Last

Share
Profile

Follow
ANPto2Dollars

351 Posts.

130

31/08/24

03:38

Post #: 75466563
Share

Originally posted by Deanostock: ↑

Compare the Pair:
Varying approach between 2 regularly compared coys on this thread by one poster who loves posting volume over quality. Its pretty interesting for those who have the ability to take a balanced view, especially when you look at ability to raise, achievements over the year and attracting and retaining cornerstone investment.

The below is board only, so doesn't include AF taking 1/3 of the FT expense (or ciorca $600k) for no published achievements or any of the Coles (down down) oppies. FWIW PYC didnt give out any oppies outside of staff and that was very very limited, thats because they have a policy of aligning with holder expectations and a chair who just wouldnt put up with that $hit as you can see below. The lack of opacity at PYC is also interesting, you can read through and see exactly what happened and how rewards are determined. To be clear, I hold both...

From the PYC report.... Clear and detailed

From the PER report... Loose AF

REM comparison...

Are you content that CG, JG and GP are acting in your best interests and ""reduced some significant costs, for example by eliminating manyconsultants and relocating our office to a less expensive location", or, as the above demonstrates, reduced significant costs so we can increase board member payments, ceo salaries and start dishing out ridiculous bonuses for doing the job you are paid to do....

Take a look at the facts, objectively.... and then..
If you think this is heading into rort territory I encourage you to contact the board and voice your disgust. If not, feel free to rip into me and provide FACTS as to how I am wrong.

GLAH

Expand

Wow. Incredibly damning. A looting, even.

PER Price at posting: 8.7¢ Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BUX

Buxton projects new graphite province discovery at WA Narryer play

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

There are more pages in this discussion • 48 more messages in this thread...

First 27 Last

Add PER (ASX) to my watchlist

(20min delay)
Last 10.5¢		Change 0.000(0.00%)		Mkt cap ! $94.66M

Open	High	Low	Value	Volume
10.5¢	10.5¢	9.8¢	$58.09K	574.8K

Buyers (Bids)

No.	Vol.	Price($)
1	38503	10.0¢

Sellers (Offers)

Price($)	Vol.	No.
10.5¢	194063	5

View Market Depth

No.	Vol.	Price($)
1	100000	0.099
2	108491	0.098
1	30927	0.097
1	10004	0.096
3	162157	0.095

Price($)	Vol.	No.
0.105	194063	5
0.110	254663	3
0.115	1334300	6
0.120	381142	9
0.125	110429	2

Last trade - 16.10pm 04/10/2024 (20 minute delay)

PER (ASX) Chart

Ann: Appendix 4E and Annual Report, page-27

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Buxton projects new graphite province discovery at WA Narryer play

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BCI reaches close of funding facility for salt-first part of Mardie project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Appendix 4E and Annual Report, page-27

Top Stories

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Buxton projects new graphite province discovery at WA Narryer play

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BCI reaches close of funding facility for salt-first part of Mardie project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News